Laurie J. Hall Trustee’s Ultragenyx Pharmaceutical RARE Stock Holding History

Laurie J. Hall Trustee’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-40	Closed	-$2K	–	305
2022 Q4	$2K	Sell	40 -20	-33%	-$787	﹤0.01%	287
2022 Q3	$2K	Sell	60 -30	-33%	-$1.54K	﹤0.01%	299
2022 Q2	$5K	Hold	90	–	–	﹤0.01%	288
2022 Q1	$7K	Hold	90	–	–	﹤0.01%	287
2021 Q4	$8K	Hold	90	–	–	﹤0.01%	284
2021 Q3	$8K	Sell	90 -50	-36%	-$4.52K	﹤0.01%	285
2021 Q2	$13K	Hold	140	–	–	﹤0.01%	276
2021 Q1	$16K	Hold	140	–	–	0.01%	275
2020 Q4	$19K	Hold	140	–	–	0.01%	255
2020 Q3	$12K	Buy	+140	New	+$11.6K	0.01%	259
2019 Q4	$4K	Buy	+100	New	+$4.13K	﹤0.01%	305

Other funds holding RARE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Laurie J. Hall Trustee's RARE Position: Q1 2023 in Review

Laurie J. Hall Trustee sold out of Ultragenyx Pharmaceutical (RARE) in Q1 2023, closing a stake of 40 shares — an estimated $2K sold.

Laurie J. Hall Trustee first reported a position in RARE in Q4 2019 and held it in 11 quarters. The position peaked at $19K in Q4 2020. 228 funds tracked by Wall St. Rank hold RARE as of Q1 2023.

Laurie J. Hall Trustee reported no remaining Ultragenyx Pharmaceutical position as of Q1 2023 after selling out during the quarter.
Laurie J. Hall Trustee sold 40 Ultragenyx Pharmaceutical shares in Q1 2023, an estimated $2K.
Laurie J. Hall Trustee first reported a position in Ultragenyx Pharmaceutical in Q4 2019 and held it in 11 quarters.
Laurie J. Hall Trustee's Ultragenyx Pharmaceutical position peaked at $19K in Q4 2020.
228 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2023.

Based on Laurie J. Hall Trustee's 13F filing for Q1 2023, filed 7 Apr 2023.